【冠狀動脈】「HART CADhs®」: 結合多蛋白血液檢查與ML識別「CAD」，獲FDA突破性醫材

 【冠狀動脈】「HART CADhs®」: 結合多蛋白血液檢查與ML識別「阻塞性冠狀動脈疾病(CAD)」，獲FDA突破性醫材

 文章出處  

Businesswire 

 

 原文標題  

Prevencio Receives FDA Breakthrough Device Designation for HART CADhs, Its Artificial Intelligence-driven Blood Test for Obstructive Coronary Artery Disease 

 

 Twitter  

https://x.com/aimedadviser/status/1922815776035307569 

 

 文章序號  

7985 

 

智醫科學－AI醫療技術、應用與市場動態

Copyright ©2025 智醫科學 MEDai.tw All rights reserved.

The content of this site is intended for healthcare and medical professionals.